Cargando…

晚期肺腺癌患者一线治疗前后EGFR基因突变差异性分析

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR)-based targeted therapy improves the survival of patients with advanced lung adenocarcinoma harboring EGFR mutations. However, factors including treatment or heterogeneity partly contribute to EGFR genetic status alteration between bas...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246999/
https://www.ncbi.nlm.nih.gov/pubmed/30454543
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.11.03